- Home
- WBS vs RGEN Comparison
WBS vs RGEN Comparison
Compare WBS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBS
- RGEN
- Stock Information
- Founded
- WBS 1935
- RGEN 1981
- Country
- WBS United States
- RGEN United States
- Employees
- WBS N/A
- RGEN N/A
- Industry
- WBS Major Banks
- RGEN Medical/Dental Instruments
- Sector
- WBS Finance
- RGEN Health Care
- Exchange
- WBS Nasdaq
- RGEN Nasdaq
- Market Cap
- WBS 9.1B
- RGEN 8.0B
- IPO Year
- WBS N/A
- RGEN N/A
- Fundamental
- Price
- WBS $51.49
- RGEN $118.07
- Analyst Decision
- WBS Strong Buy
- RGEN Buy
- Analyst Count
- WBS 13
- RGEN 12
- Target Price
- WBS $63.38
- RGEN $172.67
- AVG Volume (30 Days)
- WBS 1.1M
- RGEN 791.0K
- Earning Date
- WBS 06-26-2025
- RGEN 04-29-2025
- Dividend Yield
- WBS 3.11%
- RGEN N/A
- EPS Growth
- WBS N/A
- RGEN N/A
- EPS
- WBS 4.44
- RGEN N/A
- Revenue
- WBS $2,372,492,000.00
- RGEN $650,429,000.00
- Revenue This Year
- WBS $10.11
- RGEN $13.93
- Revenue Next Year
- WBS $5.18
- RGEN $14.35
- P/E Ratio
- WBS $11.60
- RGEN N/A
- Revenue Growth
- WBS N/A
- RGEN 4.88
- 52 Week Low
- WBS $39.34
- RGEN $102.97
- 52 Week High
- WBS $63.99
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- WBS 54.03
- RGEN 39.80
- Support Level
- WBS $49.81
- RGEN $120.55
- Resistance Level
- WBS $52.69
- RGEN $123.71
- Average True Range (ATR)
- WBS 1.15
- RGEN 4.63
- MACD
- WBS -0.11
- RGEN -0.58
- Stochastic Oscillator
- WBS 43.19
- RGEN 7.59
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.